Look for:

Our offer for

BIOGEN IDEC INC.


ISIN:
US09062X1037
WKN:
09062X103

2024/02/21 22:00:00
Price
221.11 USD
Difference 0.87% (1.90)

General attributes

ISINUS09062X1037
SymbolBIIB
ExchangeNasdaq
CurrencyUSD
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)29,636 EUR
BenchmarkS&P 500

Market data

Bid (Bid size)220.00 USD (500)
Ask (Ask size)223.94 USD (100)
Open221.49 USD
High223.41 USD
Low219.00 USD
Close (prev. day)219.21 USD
VWAP221.121868 USD
Volume (pcs)1,055,024
Trading volume233,247,921.91
Number of trades22,752
Last size100,094

Futures and Options

Related Futures-
Related Options-

PDF Downloads

Company report: BIOGEN IDEC INC.PDF Download

Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Recent research



2024/02/21 22:00:00
Price
221.11 USD
Difference 0.87% (1.90)

General attributes

ISINUS09062X1037
SymbolBIIB
ExchangeNasdaq
CurrencyUSD
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)29,636 EUR
BenchmarkS&P 500

Market data

Bid (Bid size)220.00 USD (500)
Ask (Ask size)223.94 USD (100)
Open221.49 USD
High223.41 USD
Low219.00 USD
Close (prev. day)219.21 USD
VWAP221.121868 USD
Volume (pcs)1,055,024
Trading volume233,247,921.91
Number of trades22,752
Last size100,094

Performance and Risk

6m1Y3Y
Perf (%)-16.58%-18.69%-20.56%
Perf (abs.)-43.96-50.82-57.24
Beta0.860.740.80
Volatility25.1322.7339.19
Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Price data

Ø price 5 days | Ø volume 5 days (pcs.)220.69 USD (1,623,432)
Ø price 30 days | Ø volume 30 days (pcs.)241.63 USD (1,126,006)
Ø price 100 days | Ø volume 100 days (pcs.)245.45 USD (1,095,216)
Ø price 250 days | Ø volume 250 days (pcs.)266.08 USD (1,028,242)
YTD High | date268.30 USD (2024/01/03)
YTD Low | date215.68 USD (2024/02/20)
52 Weeks High | date319.76 USD (2023/06/12)
52 Weeks Low | date215.68 USD (2024/02/20)

All listings for BIOGEN IDEC INC.

Exchange  DateTimePriceTrading volume (mio.)Number of trades
Xetra2024/02/2117:35204.80 EUR0.004
Vienna Stock Exchange2024/02/2117:32204.80 EUR0.002
Tradegate2024/02/2122:26204.40 EUR0.0720
Stuttgart2024/02/2120:27203.40 EUR0.004
SIX Swiss Exchange2022/09/2817:36222.00 CHF0.001
Nasdaq2024/02/2122:00221.11 USD233.2522,752
Munich2024/02/2108:00201.80 EUR0.002
London Stock Exchange2024/02/1615:50220.16 USD0.006
Hanover2024/02/2108:09201.80 EUR0.003
Hamburg2024/02/2108:12201.80 EUR0.001
Frankfurt2024/02/2119:35206.00 EUR0.021
Euronext Milan MTF Trading After Hours2024/02/1618:25205.40 EUR0.001
Euronext Milan MTF Global Equity Market2024/02/2117:44204.60 EUR0.013
Duesseldorf2024/02/2119:30203.60 EUR0.007
Berlin2024/02/2121:48204.20 EUR0.0019
BX Swiss2024/01/1718:00211.504 CHF0.001

Company Logo

https://gateway.mdgms.com/extern/logo_image.html?ID_LOGO=2033&ID_TYPE_IMAGE_LOGO=2

Contact Details

BIOGEN INC.
- -
225 Binney Street - 02142 Cambridge
Telefon: +1-617-679-2000
Fax: +
E-mail: info@biogen.com

PDF Downloads

Company report: BIOGEN IDEC INC.PDF Download

Company Profile

Biogen, Inc. is a biopharmaceutical company, which engages in discovering, developing, and delivering therapies for neurological and neurodegenerative diseases. Its products include TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI and FAMPYRA for the treatment of MS, SPINRAZA for the treatment of SMA, ADUHELM for the treatment of Alzheimer's disease, and FUMADERM for the treatment of severe plaque psoriasis. The company was founded by Charles Weissmann, Heinz Schaller, Kenneth Murray, Walter Gilbert, and Phillip Allen Sharp in 1978 and is headquartered in Cambridge, MA.

Members of Management Board

Caroline DorsaChairman of Board of Directors
Eric RowinskyMember of Board of Directors
Maria FreireMember of Board of Directors
Stephen SherwinMember of Board of Directors
Jesus MantasMember of Board of Directors
Monish PatolawalaMember of Board of Directors
Susan LangerMember of Board of Directors
William HawkinsMember of Board of Directors
Michel VounatsosChairman of Managing Board
Ginger GregoryMember of Executive Committee
Alphonse GaldesMember of Executive Committee
Michael McDonnellMember of Executive Committee
Rachid IzzarMember of Executive Committee
Susan H. AlexanderMember of Executive Committee






Decline
Accept

We use cookies and web analysis software to give you the best possible experience on our website. If you consent, these tools will be used. Please read more information here

INFORMATION FOR PRIVATE CLIENTS / CONSUMERS

Any information, material and services regarding financial instruments and securities provided by Česká spořitelna/Erste Group/ or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites“) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions.

By agreeing to this hereto, the visitor entering this Websites confirms that has read, understood and accepted this Information and the Disclaimer